Resources
for You and Your Team
Navigating the Future of AI in Healthcare: 3 State Law Trends to Watch
Explore how state laws are shaping the future of AI in healthcare, focusing on transparency, consumer rights, and algorithmic fairness. As regulations evolve, healthcare AI innovators must adapt to ensure compliance and equitable outcomes in a multi-jurisdictional landscape.
Venture Debt: Considerations for Healthcare Innovation Companies
Explore how venture debt can offer healthcare innovation companies non-dilutive capital to fuel growth, bridge equity rounds, and scale operations, while navigating key legal and financial considerations to maximize value.
Fundraising at Every Stage: Top Tips for Digital Health Startups
Learn how to make the fundraising process go as smoothly – and as quickly – as possible as a digital health startup — whether you're raising for the first time or you're a Series C company preparing for exit.
Point Solution Fatigue, Meet M&A: How Strategic Transactions Can Transform Digital Health
Explore how strategic mergers and acquisitions (M&A) can reduce or even eliminate point solution fatigue by creating more comprehensive and integrated platforms that will improve patient care and reduce administrative burden.
Navigating Reimbursement Strategies in the Food as Medicine Space
One of the key factors in FaM’s growth is reimbursement policy across various payors and providers. This post introduces reimbursement frameworks and strategies that support the FaM space, including medical nutrition therapy (MNT), medically tailored meals (MTM), the Supplemental Nutrition Assistance Program (SNAP), and employer-sponsored benefits programs.
FTC Finalizes Changes to Health Breach Notification Rule: What Digital Health Companies and App Developers Need to Know
The Federal Trade Commission (FTC) finalized changes to the Health Breach Notification Rule (HBNR), clarifying its applicability to health apps and similar technologies, including those that are not subject to HIPAA. In 2023, FTC began enforcing the HBNR in earnest, with an expanded interpretation of their authority under the HBNR. In the 2024 Final Rule (the 2024 Final Rule), the agency conforms the HBNR to this expanded interpretation, clarifying its breadth for industry and the public.
FDA Enforcement Discretion: A Strategic Path to Market for Digital Health and Digital Therapeutics Companies
Healthcare delivery is changing, and digital health is revolutionizing healthcare, creating a burgeoning market opportunity for software-as-a-medical-device (SaMD) and digital therapeutic (DTx) products.
Colorado’s New AI Law Sets “National Standard” for Healthcare AI: 5 Things Developers and Deployers Need to Know, Now
Last Friday, Colorado’s governor signed into law the Colorado AI Act (“CAIA”). For digital health companies building with artificial intelligence, CAIA sets the first comprehensive national benchmark for minimum rights and protections for users of healthcare AI, effective February 1, 2026.
Nixon Law Group Expands Corporate, Mergers and Acquisitions, Venture Capital, and Health Tech Capabilities with Four New Attorneys
The Top 3 Legal Considerations for Pediatric Digital Health Companies
Your Guide to Virtual Reality Reimbursement in the U.S. Healthcare Market
A Primer on Telepharmacy
Gain a high-level understanding of telepharmacy and how you can use and implement telepharmacy to positively impact patients, pharmacies, and healthcare providers
How to Integrate Direct-to-Consumer (DTC) Lab Testing into Your Telemedicine Model
There are two primary structures in use in the DTC space: (1) Outsourcing and (2) Insourcing.
In this article, you’ll gain an overview of each structure, discover the limitations regarding billing and revenue model, and walk away with key operational considerations.
FDA Issues Final Guidance on Clinical Decision Support Software and Software as a Medical Device: Key Takeaways and What it Means for Digital Health Companies
